155 filings
10-K
2023 FY
XGN
Exagen Inc
Annual report
18 Mar 24
9:26am
8-K
XGN
Exagen Inc
18 Mar 24
Exagen Inc. Reports Strong Fourth Quarter and Full-Year 2023 Results
8:00am
8-K
XGN
Exagen Inc
8 Jan 24
Exagen Inc. Announces Select Preliminary Full-Year 2023 Results and Reaffirms Guidance
8:00am
8-K
XGN
Exagen Inc
11 Dec 23
Departure of Directors or Certain Officers
4:05pm
EFFECT
XGN
Exagen Inc
30 Nov 23
Notice of effectiveness
12:15am
424B5
09axqc7jr7
29 Nov 23
Prospectus supplement for primary offering
5:11pm
CORRESP
odan0oi1pui5eqxg
28 Nov 23
Correspondence with SEC
12:00am
UPLOAD
1wiemh
22 Nov 23
Letter from SEC
12:00am
424B5
qkny4jg
20 Nov 23
Prospectus supplement for primary offering
8:00am
8-K
whgwblwn0c ov5n9
17 Nov 23
Entry into a Material Definitive Agreement
4:30pm
8-K
cjtxqajkr8zer8
13 Nov 23
Exagen Inc. Reports Strong Third Quarter 2023 Results
4:05pm
8-K
j90ur7j
26 Oct 23
Entry into a Material Definitive Agreement
4:05pm
8-K
754gx hqhamtcb
7 Aug 23
Exagen Inc. Reports Strong Second Quarter 2023 Results
8:00am
8-K
he2m803 isme
24 Jul 23
Exagen Inc. Appoints Paul Kim to Board of Directors
4:05pm
8-K
lcxr4yk60lbl33q8m
14 Jun 23
Submission of Matters to a Vote of Security Holders
4:50pm
DEFA14A
djxglfeo1vvs ch
24 May 23
Additional proxy soliciting materials
4:05pm